{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T13:32:26Z","timestamp":1773495146534,"version":"3.50.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The aberrant expression of the mesenchymal FGFR2c variant in pancreatic ductal adenocarcinoma (PDAC)-derived cells enhances EMT and tumorigenic features, with PKC\u03b5-dependent signaling emerging as the main downstream pathway involved. Since lipid rafts are specialized microdomains functioning as signaling hubs and considering their relevance in the induction of EMT and cell invasion in cancer, their potential contribution in FGFR2c-mediated tumorigenesis cannot be excluded. In this study, we aimed to assess whether a possible link exists between lipid raft stability and the oncogenic activity of FGFR2c by analyzing the impact of raft perturbation on the establishment of the aberrant FGFR2c\/PKC\u03b5 axis in PDAC cells. Immunofluorescence and biochemical analyses revealed that ligand-dependent activation of FGFR2c led to an increased localization of the receptor within lipid rafts. Moreover, disruption of lipid rafts by methyl \u03b2-cyclodextrin (M\u03b2CD) attenuated the FGFR2c downstream signaling, as well as the consequent enhancement of EMT and of MCL1\/SRC-mediated cell invasion. In addition, co-immunoprecipitation experiments, coupled to gene silencing approaches, highlighted the cation channel TRPA1 as a potential contributor to FGFR2c oncogenic signaling by regulating its recruitment to cholesterol-enriched signaling platforms. Overall, our findings indicate that FGFR2c, TRPA1 and lipid raft components represent promising targets for the development of novel cancer type-specific therapeutic strategies.<\/jats:p>","DOI":"10.1038\/s41419-026-08513-7","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T12:57:12Z","timestamp":1771937832000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Role of lipid rafts in the FGFR2c-mediated oncogenic signaling by involvement of TRPA1 channel in pancreatic ductal adenocarcinoma cells"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5176-2724","authenticated-orcid":false,"given":"Vanessa","family":"Mancini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Manganelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0645-2510","authenticated-orcid":false,"given":"Tina","family":"Garofalo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Sorice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Raffa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dafne","family":"Scullari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danilo","family":"Ranieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Belleudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"key":"8513_CR1","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41571-024-00869-z","volume":"21","author":"M Katoh","year":"2024","unstructured":"Katoh M, Loriot Y, Brandi G, Tavolari S, Wainberg ZA, Katoh M. FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions. Nat Rev Clin Oncol. 2024;21:312\u201329.","journal-title":"Nat Rev Clin Oncol"},{"key":"8513_CR2","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3390\/cells10040847","volume":"10","author":"EP Carter","year":"2021","unstructured":"Carter EP, Coetzee AS, Tomas Bort E, Wang Q, Kocher HM, Grose RP. Dissecting FGF signalling to target cellular crosstalk in pancreatic cancer. Cells. 2021;10:847.","journal-title":"Cells"},{"key":"8513_CR3","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.3390\/cancers16162912","volume":"16","author":"E Orlandi","year":"2024","unstructured":"Orlandi E, Guasconi M, Vecchia S, Trubini S, Giuffrida M, Proietto M, et al. Exploring the horizon: anti-fibroblast growth factor receptor therapy in pancreatic cancer with aberrant fibroblast growth factor receptor expression\u2013a scoping review. Cancers. 2024;16:2912.","journal-title":"Cancers"},{"key":"8513_CR4","doi-asserted-by":"publisher","first-page":"5440","DOI":"10.18632\/oncotarget.6706","volume":"7","author":"D Ranieri","year":"2016","unstructured":"Ranieri D, Rosato B, Nanni M, Magenta A, Belleudi F, Torrisi MR. Expression of the FGFR2 mesenchymal splicing variant in epithelial cells drives epithelial-mesenchymal transition. Oncotarget. 2016;7:5440.","journal-title":"Oncotarget"},{"key":"8513_CR5","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/mc.22754","volume":"57","author":"D Ranieri","year":"2018","unstructured":"Ranieri D, Rosato B, Nanni M, Belleudi F, Torrisi MR. Expression of the FGFR2c mesenchymal splicing variant in human keratinocytes inhibits differentiation and promotes invasion. Mol Carcinog. 2018;57:272\u201328.","journal-title":"Mol Carcinog"},{"key":"8513_CR6","doi-asserted-by":"publisher","first-page":"4993","DOI":"10.3390\/cancers13194993","volume":"13","author":"D Ranieri","year":"2021","unstructured":"Ranieri D, Guttieri L, Raffa S, Torrisi MR, Belleudi F. Role of FGFR2c and its PKC\u03b5 downstream signaling in the control of EMT and autophagy in pancreatic ductal adenocarcinoma cells. Cancers. 2021;13:4993.","journal-title":"Cancers"},{"key":"8513_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12964-020-00582-1","volume":"18","author":"D Ranieri","year":"2020","unstructured":"Ranieri D, Nanni M, Persechino F, Torrisi MR, Belleudi F. Role of PKC\u03b5 in the epithelial-mesenchymal transition induced by FGFR2 isoform switch. Cell Commun Signal. 2020;18:1\u201313.","journal-title":"Cell Commun Signal"},{"key":"8513_CR8","doi-asserted-by":"publisher","first-page":"6534","DOI":"10.3390\/ijms22126534","volume":"22","author":"D Ranieri","year":"2021","unstructured":"Ranieri D, French D, Raffa S, Guttieri L, Torrisi MR, Belleudi F. Expression of the E5 oncoprotein of HPV16 impacts on the molecular profiles of EMT-related and differentiation genes in ectocervical low-grade lesions. Int J Mol Sci. 2021;22:6534.","journal-title":"Int J Mol Sci"},{"key":"8513_CR9","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3390\/cancers16030609","volume":"16","author":"V Mancini","year":"2024","unstructured":"Mancini V, Raffa S, Fiorio Pla A, French D, Torrisi MR, Ranieri D, et al. TRPA1 contributes to FGFR2c signaling and to its oncogenic outcomes in pancreatic ductal adenocarcinoma-derived cell lines. Cancers. 2024;16:609.","journal-title":"Cancers"},{"key":"8513_CR10","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.3390\/ph17121657","volume":"17","author":"D Cucu","year":"2024","unstructured":"Cucu D. The potential of TRPA1 as a therapeutic target in cancer\u2013a study using bioinformatic tools. Pharmaceuticals. 2024;17:1657.","journal-title":"Pharmaceuticals"},{"key":"8513_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00983-w","volume":"8","author":"J Berrout","year":"2017","unstructured":"Berrout J, Kyriakopoulou E, Moparthi L, Hogea AS, Berrout L, Ivan C, et al. TRPA1-FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p. Nat Commun. 2017;8:947.","journal-title":"Nat Commun"},{"key":"8513_CR12","doi-asserted-by":"publisher","first-page":"lb266","DOI":"10.1096\/fasebj.2019.33.1_supplement.lb266","volume":"33","author":"E Kyriakopoulou","year":"2019","unstructured":"Kyriakopoulou E, Nikita G. FGFR2 and TRPA1 Interaction in Lung Cancer. FASEB J. 2019;33:lb266\u2013lb266.","journal-title":"FASEB J"},{"key":"8513_CR13","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.ccell.2018.05.001","volume":"33","author":"N Takahashi","year":"2018","unstructured":"Takahashi N, Chen HY, Harris IS, Stover DG, Selfors LM, Bronson RT, et al. Cancer cells co-opt the neuronal redox-sensing channel TRPA1 to promote oxidative-stress tolerance. Cancer Cell. 2018;33:985\u20131003.e7.","journal-title":"Cancer Cell"},{"key":"8513_CR14","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.21037\/tlcr-2025-114","volume":"14","author":"D O\u2019Connor","year":"2025","unstructured":"O\u2019Connor D, Finn SP, Gray SG. The role of TRPA1 in lung cancer. Transl Lung Cancer Res. 2025;14:4604\u201317.","journal-title":"Transl Lung Cancer Res"},{"key":"8513_CR15","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1016\/j.ajpath.2012.01.020","volume":"180","author":"T Ishiwata","year":"2012","unstructured":"Ishiwata T, Matsuda Y, Yamamoto T, Uchida E, Korc M, Naito Z. Enhanced expression of fibroblast growth factor receptor 2 IIIc promotes human pancreatic cancer cell proliferation. Am J Pathol. 2012;180:1928\u201341.","journal-title":"Am J Pathol"},{"key":"8513_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81250-3","volume":"11","author":"F Cojocaru","year":"2021","unstructured":"Cojocaru F, \u015eelescu T, Domoco\u015f D, M\u0103ru\u0163escu L, Chiritoiu G, Chelaru NR, et al. Functional expression of the transient receptor potential ankyrin type 1 channel in pancreatic adenocarcinoma cells. Sci Rep. 2021;11:2018.","journal-title":"Sci Rep"},{"key":"8513_CR17","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.3390\/biomedicines10071652","volume":"10","author":"D Ranieri","year":"2022","unstructured":"Ranieri D, French D, Persechino F, Guttieri L, Torrisi MR, Belleudi F. The FGFR2c\/PKC\u03b5 axis controls MCL-1-mediated invasion in pancreatic ductal adenocarcinoma cells: perspectives for innovative target therapies. Biomedicines. 2022;10:1652.","journal-title":"Biomedicines"},{"key":"8513_CR18","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrm.2017.16","volume":"18","author":"E Sezgin","year":"2017","unstructured":"Sezgin E, Levental I, Mayor S, Eggeling C. The mystery of membrane organization: composition, regulation and roles of lipid rafts. Nat Rev Mol Cell Biol. 2017;18:361\u201374.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8513_CR19","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3390\/ijms22020726","volume":"22","author":"M Codini","year":"2021","unstructured":"Codini M, Garcia-Gil M, Albi E. Cholesterol and sphingolipid-enriched lipid rafts as therapeutic targets in cancer. Int J Mol Sci. 2021;22:726.","journal-title":"Int J Mol Sci"},{"key":"8513_CR20","doi-asserted-by":"publisher","first-page":"622908","DOI":"10.3389\/fcell.2021.622908","volume":"9","author":"R Vona","year":"2021","unstructured":"Vona R, Iessi E, Matarrese P. Role of cholesterol and lipid rafts in cancer signaling: a promising therapeutic opportunity? Front Cell Dev Biol. 2021;9:622908.","journal-title":"Front Cell Dev Biol"},{"key":"8513_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41420-025-02321-2","volume":"11","author":"C Duranti","year":"2025","unstructured":"Duranti C, Iorio J, Manganelli V, Bagni G, Colasurdo R, Lottini T, et al. Targeting the hERG1\/\u03b21 integrin complex in lipid rafts potentiates statins anti-cancer activity in pancreatic cancer. Cell Death Discov. 2025;11:39.","journal-title":"Cell Death Discov"},{"key":"8513_CR22","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1177\/1535370219870771","volume":"244","author":"A Hryniewicz-Jankowska","year":"2019","unstructured":"Hryniewicz-Jankowska A, Augoff K, Sikorski AF. The role of cholesterol and cholesterol-driven membrane raft domains in prostate cancer. Exp Biol Med. 2019;244:1053\u201361.","journal-title":"Exp Biol Med"},{"key":"8513_CR23","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1158\/0008-5472.CAN-18-3295","volume":"79","author":"S Jiang","year":"2019","unstructured":"Jiang S, Wang X, Song D, Liu X, Gu Y, Xu Z, et al. Cholesterol induces epithelial-to-mesenchymal transition of prostate cancer cells by suppressing degradation of EGFR through APMAP. Cancer Res. 2019;79:3063\u201375.","journal-title":"Cancer Res"},{"key":"8513_CR24","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1194\/jlr.TR119000439","volume":"61","author":"F Mollinedo","year":"2020","unstructured":"Mollinedo F, Gajate C. Lipid rafts as signaling hubs in cancer cell survival\/death and invasion: implications in tumor progression and therapy: thematic review series: biology of lipid rafts. J Lipid Res. 2020;61:611\u201335.","journal-title":"J Lipid Res"},{"key":"8513_CR25","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1002\/ijc.34443","volume":"152","author":"H Jin","year":"2023","unstructured":"Jin H, Koh M, Lim H, Yong HY, Kim ES, Kim SY, et al. Lipid raft protein flotillin-1 is important for the interaction between SOS1 and H-Ras\/K-Ras, leading to Ras activation. Int J Cancer. 2023;152:1933\u201346.","journal-title":"Int J Cancer"},{"key":"8513_CR26","doi-asserted-by":"publisher","first-page":"16814","DOI":"10.3390\/ijms242316814","volume":"24","author":"M Gyoten","year":"2023","unstructured":"Gyoten M, Luo Y, Fujiwara-Tani R, Mori S, Ogata R, Kishi S, et al. Lovastatin treatment inducing apoptosis in human pancreatic cancer cells by inhibiting cholesterol rafts in plasma membrane and mitochondria. Int J Mol Sci. 2023;24:16814.","journal-title":"Int J Mol Sci"},{"key":"8513_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1158\/0008-5472.CAN-20-2199","volume":"81","author":"JD Greenlee","year":"2021","unstructured":"Greenlee JD, Subramanian T, Liu K, King MR. Rafting down the metastatic cascade: the role of lipid rafts in cancer metastasis, cell death, and clinical outcomes. Cancer Res. 2021;81:5\u201317.","journal-title":"Cancer Res"},{"key":"8513_CR28","first-page":"219","volume":"9","author":"X Ding","year":"2019","unstructured":"Ding X, Zhang W, Li S, Yang H. The role of cholesterol metabolism in cancer. Am J Cancer Res. 2019;9:219.","journal-title":"Am J Cancer Res"},{"key":"8513_CR29","doi-asserted-by":"publisher","first-page":"404","DOI":"10.4330\/wjc.v7.i7.404","volume":"7","author":"R DuBroff","year":"2015","unstructured":"DuBroff R, de Lorgeril M. Cholesterol confusion and statin controversy. World J Cardiol. 2015;7:404.","journal-title":"World J Cardiol"},{"key":"8513_CR30","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.bone.2008.02.009","volume":"42","author":"Dufour","year":"2008","unstructured":"Dufour, Guenou C, Kaabeche H, Bouvard K, Sanjay D, Marie A, et al. FGFR2-Cbl interaction in lipid rafts triggers attenuation of PI3K\/Akt signaling and osteoblast survival. Bone. 2008;42:1032\u20139.","journal-title":"Bone"},{"key":"8513_CR31","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/glia.20818","volume":"57","author":"MR Bryant","year":"2009","unstructured":"Bryant MR, Marta CB, Kim FS, Bansal R. Phosphorylation and lipid raft association of fibroblast growth factor receptor-2 in oligodendrocytes. Glia. 2009;57:935\u201346.","journal-title":"Glia"},{"key":"8513_CR32","doi-asserted-by":"publisher","first-page":"593319","DOI":"10.3389\/fphar.2020.593319","volume":"11","author":"\u00c1 Horv\u00e1th","year":"2021","unstructured":"Horv\u00e1th \u00c1, Payrits M, Steib A, K\u00e1nt\u00e1s B, Bir\u00f3-S\u00fct T, Erosty\u00e1k J, et al. Analgesic effects of lipid raft disruption by sphingomyelinase and myriocin via transient receptor potential vanilloid 1 and transient receptor potential ankyrin 1 ion channel modulation. Front Pharmacol. 2021;11:593319.","journal-title":"Front Pharmacol"},{"key":"8513_CR33","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1002\/jcp.30679","volume":"237","author":"D Bobkov","year":"2022","unstructured":"Bobkov D, Semenova S. Impact of lipid rafts on transient receptor potential channel activities. J Cell Physiol. 2022;237:2034\u201344.","journal-title":"J Cell Physiol"},{"key":"8513_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55\u201363.","journal-title":"J Immunol Methods"},{"key":"8513_CR35","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1083\/jcb.108.3.821","volume":"108","author":"JE Skibbens","year":"1989","unstructured":"Skibbens JE, Roth MG, Matlin KS. Differential extractability of influenza virus hemagglutinin during intracellular transport in polarized epithelial cells and nonpolar fibroblasts. J Cell Biol. 1989;108:821\u201332.","journal-title":"J Cell Biol"},{"key":"8513_CR36","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1093\/rheumatology\/key174","volume":"57","author":"V Manganelli","year":"2018","unstructured":"Manganelli V, Recalchi S, Capozzi A, Riitano G, Mattei V, Longo A, et al. Autophagy induces protein carbamylation in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Rheumatology. 2018;57:2032\u201341.","journal-title":"Rheumatology"},{"key":"8513_CR37","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/1471-2105-13-134","volume":"13","author":"J Ye","year":"2012","unstructured":"Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S, Madden TL. Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinform. 2012;13:134.","journal-title":"BMC Bioinform"},{"key":"8513_CR38","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.1038\/onc.2013.392","volume":"33","author":"J Ueda","year":"2014","unstructured":"Ueda J, Matsuda Y, Yamahatsu K, Uchida E, Nait Z, Korc M, et al. Epithelial splicing regulatory protein 1 is a favorable prognostic factor in pancreatic cancer that attenuates pancreatic metastases. Oncogene. 2014;33:4485\u201395.","journal-title":"Oncogene"},{"key":"8513_CR39","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3390\/toxins13080543","volume":"13","author":"AK Kenworthy","year":"2021","unstructured":"Kenworthy AK, Schmieder SS, Raghunathan K, Tiwari A, Wang T, Kelly CV, et al. Cholera toxin as a probe for membrane biology. Toxins. 2021;13:543.","journal-title":"Toxins"},{"key":"8513_CR40","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0092-8674(01)00472-X","volume":"106","author":"F Galbiati","year":"2001","unstructured":"Galbiati F, Razani B, Lisanti MP. Emerging themes in lipid rafts and caveolae. Cell. 2001;106:403\u201311.","journal-title":"Cell"},{"key":"8513_CR41","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.mcn.2018.01.007","volume":"88","author":"T Garofalo","year":"2018","unstructured":"Garofalo T, Ferri A, Sorice M, Azmoon P, Grasso M, Mattei V, et al. Neuroglobin overexpression plays a pivotal role in neuroprotection through mitochondrial raft-like microdomains in neuroblastoma SK-N-BE2 cells. Mol Cell Neurosci. 2018;88:167\u201376.","journal-title":"Mol Cell Neurosci"},{"key":"8513_CR42","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1080\/19336918.2017.1393591","volume":"12","author":"AI Young","year":"2018","unstructured":"Young AI, Timpson P, Gallego-Ortega D, Ormandy CJ, Oakes SR. Myeloid cell leukemia 1 (MCL-1), an unexpected modulator of protein kinase signaling during invasion. Cell Adh Migr. 2018;12:513\u201323.","journal-title":"Cell Adh Migr"},{"key":"8513_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-021-00750-x","volume":"19","author":"MA Ortiz","year":"2021","unstructured":"Ortiz MA, Mikhailova T, Li X, Porter BA, Bah A, Kotula L. Src family kinases, adaptor proteins and the actin cytoskeleton in epithelial-to-mesenchymal transition. Cell Commun Signal. 2021;19:67.","journal-title":"Cell Commun Signal"},{"key":"8513_CR44","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1038\/s41388-019-1091-0","volume":"39","author":"L Castillo","year":"2020","unstructured":"Castillo L, Young AIJ, Mawson A, Schafranek P, Steinmann AM, Nessem D, et al. MCL-1 antagonism enhances the anti-invasive effects of dasatinib in pancreatic adenocarcinoma. Oncogene. 2020;39:1821\u20139.","journal-title":"Oncogene"},{"key":"8513_CR45","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.1016\/j.cub.2022.06.038","volume":"32","author":"K Kajiwara","year":"2022","unstructured":"Kajiwara K, Chen PK, Abe Y, Okuda S, Kon S, Adachi J, et al. Src activation in lipid rafts confers epithelial cells with invasive potential to escape from apical extrusion during cell competition. Curr Biol. 2022;32:3460\u201376.","journal-title":"Curr Biol"},{"key":"8513_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06447-w","volume":"23","author":"G Khalili-Tanha","year":"2025","unstructured":"Khalili-Tanha G, Radisky ES, Radisky DC, Shoari A. Matrix metalloproteinase-driven epithelial-mesenchymal transition: implications in health and disease. J Transl Med. 2025;23:436.","journal-title":"J Transl Med"},{"key":"8513_CR47","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.3390\/cancers15072169","volume":"15","author":"VB Joshi","year":"2023","unstructured":"Joshi VB, Gutierrez Ruiz OL, Razidlo GL. The cell biology of metastatic invasion in pancreatic cancer: updates and mechanistic insights. Cancers. 2023;15:2169.","journal-title":"Cancers"},{"key":"8513_CR48","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/biology9040080","volume":"9","author":"EJ Slapak","year":"2020","unstructured":"Slapak EJ, Duitman J, Tekin C, Bijlsma MF, Spek CA. Matrix metalloproteases in pancreatic ductal adenocarcinoma: key drivers of disease progression? Biology. 2020;9:80.","journal-title":"Biology"},{"key":"8513_CR49","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1042\/BJ20061061","volume":"402","author":"C Barbat","year":"2007","unstructured":"Barbat C, Trucy M, Sorice M, Garofalo T, Manganelli V, Fischer A, et al. p56lck, LFA-1 and PI3K but not SHP-2 interact with GM1-or GM3-enriched microdomains in a CD4\u2013p56lck association-dependent manner. Biochem J. 2007;402:471\u201381.","journal-title":"Biochem J"},{"key":"8513_CR50","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1186\/s12964-024-01876-4","volume":"22","author":"F Ruzzi","year":"2024","unstructured":"Ruzzi F, Cappello C, Semprini MS, Scalambra L, Angelicola S, et al. Lipid rafts, caveolae, and epidermal growth factor receptor family: friends or foes? Cell Cell Commun Signal. 2024;22:489.","journal-title":"Cell Cell Commun Signal"},{"key":"8513_CR51","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/s41417-020-0206-7","volume":"28","author":"L Huang","year":"2021","unstructured":"Huang L, Chen S, Fan H, Ji D, Chen C, Sheng W. GINS2 promotes EMT in pancreatic cancer via specifically stimulating ERK\/MAPK signaling. Cancer Gene Ther. 2021;28:839\u201349.","journal-title":"Cancer Gene Ther"},{"key":"8513_CR52","first-page":"36","volume":"6","author":"AR Safa","year":"2020","unstructured":"Safa AR. Epithelial-mesenchymal transition: a hallmark in pancreatic cancer stem cell migration, metastasis formation, and drug resistance. J Cancer Metastasis Treat. 2020;6:36.","journal-title":"J Cancer Metastasis Treat"},{"key":"8513_CR53","doi-asserted-by":"crossref","unstructured":"Liang W, Hao Z, Han JL, Zhu DJ, Jin ZF & Xie WL. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition. Urol Oncol. 2014;32:855\u201363.","DOI":"10.1016\/j.urolonc.2014.01.005"},{"key":"8513_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12957-017-1120-9","volume":"15","author":"Y Li","year":"2017","unstructured":"Li Y, Shan F, Chen J. Lipid raft-mediated miR-3908 inhibition of migration of breast cancer cell line MCF-7 by regulating the interactions between AdipoR1 and Flotillin-1. World J Surg Oncol. 2017;15:1\u201310.","journal-title":"World J Surg Oncol"},{"key":"8513_CR55","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.13901","volume":"10","author":"Y Huang","year":"2022","unstructured":"Huang Y, Guo Y, Xu Y, Liu F, Dai S. Flotillin-1 promotes EMT of gastric cancer via stabilizing Snail. PeerJ. 2022;10:e13901.","journal-title":"PeerJ"},{"key":"8513_CR56","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.bbamem.2013.07.018","volume":"1838","author":"BP Head","year":"2014","unstructured":"Head BP, Patel HH, Insel PA. Interaction of membrane\/lipid rafts with the cytoskeleton: impact on signaling and function: membrane\/lipid rafts, mediators of cytoskeletal arrangement and cell signaling. Biochim Biophys Acta. 2014;1838:532\u201345.","journal-title":"Biochim Biophys Acta"},{"key":"8513_CR57","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.3390\/ijms21113826","volume":"21","author":"JB Startek","year":"2020","unstructured":"Startek JB, Talavera K. Lipid raft destabilization impairs mouse TRPA1 responses to cold and bacterial lipopolysaccharides. Int J Mol Sci. 2020;21:3826.","journal-title":"Int J Mol Sci"},{"key":"8513_CR58","doi-asserted-by":"publisher","first-page":"34528","DOI":"10.1074\/jbc.M110.125302","volume":"285","author":"F Mollinedo","year":"2010","unstructured":"Mollinedo F, Janssen H, de la Iglesia-Vicente J, Villa-Pulgarin JA, Calafat J. Selective fusion of azurophilic granules with Leishmania-containing phagosomes in human neutrophils. J Biol Chem. 2010;285:34528\u201336.","journal-title":"J Biol Chem"},{"key":"8513_CR59","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.3390\/biom13101557","volume":"13","author":"M Marini","year":"2023","unstructured":"Marini M, Titiz M, Souza Monteiro de Ara\u00fajo D, Geppetti P, Nassini R, De Logu F. TRP channels in cancer: signaling mechanisms and translational approaches. Biomolecules. 2023;13:1557.","journal-title":"Biomolecules"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08513-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08513-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08513-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T12:02:32Z","timestamp":1773489752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08513-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8513"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08513-7","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"12 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. Ethical approval and informed consent were not necessary. All experiments were performed exclusively using commercially available immortalized cell lines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"259"}}